We recommend

  1. Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study
    Bishal Gyawali et al., The BMJ, 2021
  2. Study examines quality of evidence for drugs granted accelerated FDA approval
    MedicalXpress
  3. Comparison of novel oncology drugs that received dual approval from the US accelerated approval and EU conditional marketing authorisation pathways, 2006–2021: a cross-sectional study
    Jinping Xie et al., BMJ Open, 2023
  4. Medicare program spent $1.8 billion in 2019 on drugs without confirmed clinical benefits
    by Johns Hopkins University Bloomberg School of Public Health, MedicalXpress, 2022
Powered by
  • Targeting settings
  • Do not sell my personal information
  • Google Analytics settings
I consent to the use of Google Analytics and related cookies across the TrendMD network (widget, website, blog). Learn more